🔎 Trials Near Me

Home › Parkinson's Disease › NCT07863180

Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial

RecruitingPhase 1/2

Tributyrin for PSP: Phase 1b Virtual Trial - Feasibility Study

Who can join

Ages 45 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Male or Female, age 45 years and over.
* Diagnosis of PSP-Richardson syndrome (RS) based on Movement Disorder Society (MDS) Criteria, including

  1. Vertical supranuclear gaze palsy.
  2. Repeated unprovoked falls OR tendency to fall on the pull test within 3 years.
* Access to the internet and webcam for virtual visits.
* Presence of a caregiver.

Exclusion Criteria:

* Recent history of significant, uncontrolled GI disease such as Gastroesophageal reflux disease, colorectal cancer.
* Significant metabolic or uncontrolled medical comorbidity.
* Regular use of typical anti-cholinergic drugs.
* Women of child-bearing potential, or who are pregnant and/or nursing.
* Suicidal ideation, as indicated by a response of 2 or 3 on question 9 of the Beck Depression Inventory.
* Any other condition or criterion that, in the opinion of the investigators, would preclude safe and meaningful participation in the study.

About the study

This research is studying a supplement called tributyrin in people with Progressive Supranuclear Palsy (PSP) to learn about its safety and tolerability as a potential treatment. The goal of this research study is to see if a similar supplementation regimen and virtual testing is feasible for people with PSP.

What is being tested

Sponsor: Prabesh Kanel · Participants: 15 · Started: Oct 1, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07863180

Locations in the U.S.

MichiganDomino's Farms, Ann Arbor

Conditions

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.